Catalan healthcare company to acquire US firm Talecris
The 3.4 billion dollar purchase of Talecris Biotherapeutics will allow Grifols to occupy third spot in the US. Grifols already leads the production in Europe. While the operation will generate millions of euros, it is expected to raise Grifols? immediate